417 related articles for article (PubMed ID: 20930591)
1. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.
Williams JM; Murphy S; Burke M; Roman RJ
J Cardiovasc Pharmacol; 2010 Oct; 56(4):336-44. PubMed ID: 20930591
[TBL] [Abstract][Full Text] [Related]
2. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
[TBL] [Abstract][Full Text] [Related]
3. The role of 20-HETE in cardiovascular diseases and its risk factors.
Waldman M; Peterson SJ; Arad M; Hochhauser E
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():108-17. PubMed ID: 27287720
[TBL] [Abstract][Full Text] [Related]
4. P-450 metabolites of arachidonic acid in the control of cardiovascular function.
Roman RJ
Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611
[TBL] [Abstract][Full Text] [Related]
5. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid.
Moreno C; Maier KG; Hoagland KM; Yu M; Roman RJ
Am J Hypertens; 2001 Jun; 14(6 Pt 2):90S-97S. PubMed ID: 11411771
[TBL] [Abstract][Full Text] [Related]
6. Role of cytochrome P450 metabolites of arachidonic acid in hypertension.
Sarkis A; Roman RJ
Curr Drug Metab; 2004 Jun; 5(3):245-56. PubMed ID: 15180494
[TBL] [Abstract][Full Text] [Related]
7. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.
Roman RJ; Alonso-Galicia M; Wilson TW
Am J Hypertens; 1997 May; 10(5 Pt 2):63S-67S. PubMed ID: 9160783
[TBL] [Abstract][Full Text] [Related]
8. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
Fan F; Ge Y; Lv W; Elliott MR; Muroya Y; Hirata T; Booz GW; Roman RJ
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1427-63. PubMed ID: 27100515
[TBL] [Abstract][Full Text] [Related]
10. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
Hoagland KM; Maier KG; Roman RJ
Hypertension; 2003 Mar; 41(3 Pt 2):697-702. PubMed ID: 12623982
[TBL] [Abstract][Full Text] [Related]
11. The role of 20-HETE in androgen-mediated hypertension.
Wu CC; Schwartzman ML
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):45-53. PubMed ID: 21722750
[TBL] [Abstract][Full Text] [Related]
12. Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats.
Ge Y; Murphy SR; Fan F; Williams JM; Falck JR; Liu R; Roman RJ
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F509-15. PubMed ID: 25007877
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Certíková Chábová V; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kujal P; Vernerová Z; Vanourková Z; Kopkan L; Kramer HJ; Falck JR; Imig JD; Hammock BD; Vanecková I; Cervenka L
Clin Sci (Lond); 2010 Feb; 118(10):617-32. PubMed ID: 20050826
[TBL] [Abstract][Full Text] [Related]
14. Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice.
Stec DE; Flasch A; Roman RJ; White JA
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F95-102. PubMed ID: 12388424
[TBL] [Abstract][Full Text] [Related]
15. Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors.
Doggrell SA
Curr Opin Investig Drugs; 2005 Sep; 6(9):901-6. PubMed ID: 16187690
[TBL] [Abstract][Full Text] [Related]
16. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
Miyata N; Roman RJ
J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232
[TBL] [Abstract][Full Text] [Related]
17. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
Zhou Y; Huang H; Chang HH; Du J; Wu JF; Wang CY; Wang MH
J Pharmacol Exp Ther; 2006 Apr; 317(1):11-8. PubMed ID: 16339392
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
Hoagland KM; Flasch AK; Roman RJ
Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093
[TBL] [Abstract][Full Text] [Related]
19. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
20. Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles.
Ge Y; Murphy SR; Lu Y; Falck J; Liu R; Roman RJ
Prostaglandins Other Lipid Mediat; 2013; 102-103():42-8. PubMed ID: 23500064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
